BHI Weekly News Archives 442nd Edition, February 9, 2021 BioHealth Innovation If you are having trouble viewing this email, please click here February 9, 2021 FOUNDING MEMBER OF Brett…Super UserFebruary 8, 2021
News Rockville’s Sensei Biotherapeutics’ IPO hits $133M – Washington Business Journal It's the latest in a series of public offerings for Greater Washington life sciences companies. Image: John Celebi is CEO…Super UserFebruary 8, 2021
News BioHealth Innovation Adds Four NIH New Entrepreneurs-in-Residence Renée JG Arnold, John Reinhart, Don Rose, and Kwame Ulmer join Diverse Entrepreneurs-in-Residence (EIR) Team ROCKVILLE, MARYLAND, February 8,…Super UserFebruary 8, 2021
News University of Maryland Research Enterprise Ranked Among Top 10 Publics in NSF Higher Education R&D Survey | UMD Right Now :: University of Maryland BALTIMORE and COLLEGE PARK, Md. – The University of Maryland achieved its highest ranking ever in the National Science Foundation’s…Super UserFebruary 8, 2021
News Immunomic Therapeutics’ CEO to present at the BIO CEO & Investor Digital Conference – Bloomberg Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today that the company will present at the BIO…Super UserFebruary 8, 2021
News Exclusive: Johns Hopkins professor and biotech colleagues tout new tech to test Covid-19 vaccine response – Endpoints News Vari ants to the SARS-CoV-2 virus have emerged of late as yet an oth er threat to a pan dem…Super UserFebruary 8, 2021
News Salisbury Award Competition – Spring 2021 The Rockville-based National Foundation for Cancer Research is accepting applications through February 28 from academic laboratory and early stage start-up-based…Super UserFebruary 8, 2021
News Baltimore venture capital investor Catalio Capital Management launches new funding option – Baltimore Business Journal The new funding operation will be led by a pair of investment industry veterans who previously worked at Brown Advisory.…Super UserFebruary 8, 2021
News GSK, CureVac to develop next-generation COVID-19 vaccines | Reuters FRANKFURT, Feb 3 (Reuters) - Britain’s GlaxoSmithKline and German biotech firm CureVac struck a deal to develop next-generation vaccines against…Super UserFebruary 8, 2021
News 5 People in the BioHealth Capital Region You Should Know In 2021 – BioBuzz 2020 brought about a lot of growth across the BioHealth Capital Region (BHCR) as dozens of organizations responded with urgency…Super UserFebruary 8, 2021